TRIM28 and β-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers.
Jovčevska I, Zupanec N, Kočevar N, Cesselli D, Podergajs N, Stokin CL, Myers MP, Muyldermans S, Ghassabeh GH, Motaln H, Ruaro ME, Bourkoula E, Turnšek TL, Komel R.
Jovčevska I, et al. Among authors: kocevar n.
PLoS One. 2014 Nov 24;9(11):e113688. doi: 10.1371/journal.pone.0113688. eCollection 2014.
PLoS One. 2014.
PMID: 25419715
Free PMC article.